BlackRock Institutional Trust’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-3,708,636
Closed -$31.5M 4130
2013
Q3
$31.5M Sell
3,708,636
-266,656
-7% -$1.69M 0.01% 1523
2013
Q2
$16.3M Buy
+3,975,292
New +$21.4M ﹤0.01% 1962

BlackRock Institutional Trust's ASTX Position: Q4 2013 in Review

BlackRock Institutional Trust sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 3,708,636 shares — an estimated $31.5M sold.

BlackRock Institutional Trust first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $31.5M in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • BlackRock Institutional Trust reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • BlackRock Institutional Trust sold 3,708,636 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $31.5M.
  • BlackRock Institutional Trust first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • BlackRock Institutional Trust's ASTEX PHARMACEUTICALS, INC COM position peaked at $31.5M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on BlackRock Institutional Trust's 13F filing for Q4 2013, filed 12 Feb 2014.